6,502
edits
Changes
Jump to navigation
Jump to search
Toxoplasmosis - Cat and Dog (view source)
Revision as of 11:26, 13 August 2010
, 11:26, 13 August 2010→Treatment
The toxoplasmosis patient does not usually require hospitalisation, unless they are suffering severe disease or cannot maintain adqequate nutrition or hydration unaided. Patients showing neurological signs should also be confined and monitored.
The toxoplasmosis patient does not usually require hospitalisation, unless they are suffering severe disease or cannot maintain adqequate nutrition or hydration unaided. Patients showing neurological signs should also be confined and monitored.
Cats with suspected clinical toxoplasmosis should be
given supportive care, as required. Clindamycin
hydrochloride, administered at 12 mg/kg orally every 12
hours for four weeks, or a trimethoprim-sulphonamide
combination, administered at 15 mg/kg orally every 12
hours for four weeks, have been used most frequently by
the author for the treatment of clinical feline toxoplasmosis.
Administration of clindamycin for up to six weeks
has been shown to be safe in research cats. In one study
of cats given T gondii by carotid artery inoculation,
some clindamycin-treated cats died while untreated cats
did not (Davidson and others 1996). However, this was
apparently related to the route of inoculation; cats infected
by T gondii using the naturally occurring oral route
did not have complications induced by clindamycin
administration. Vomiting and small bowel diarrhoea
occur in some cats on clindamycin therapy. These side
effects usually develop acutely; if the drug is stopped for
one to two days and then reinstituted, it is usually tolerated.
Clindamycin has also been used successfully for
the treatment of CNS toxoplasmosis in cats (Dubey and
Lappin 1998). Some cats with CNS toxoplasmosis
require continuous treatment.
Cats that cannot tolerate clindamycin can be adminis-
'''Prevention'''
'''Prevention'''
*Cat
*Cat